OTCMKTS:FSNUY

Fresenius SE & Co. KGaA - FSNUY Stock Forecast, Price & News

$6.46

+0.16 (+2.54%)

(As of 03/27/2023 12:00 AM ET)

Add

Compare

Today's Range: $6.40
▼
$6.46
50-Day Range: $6.19
▼
$7.75
52-Week Range: $4.79
▼
$9.71

Volume: 42,004 shs
Average Volume: 36,552 shs
Market Capitalization: $14.43 billion

P/E Ratio: 9.64
Dividend Yield: 2.48%
Price Target: $31.40

Fresenius SE & Co. KGaA MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.67 Rating Score
Upside/Downside: 386.1% Upside
$31.40 Price Target
Short Interest: Healthy
0.00% of Shares Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: 19.23%
From $0.78 to $0.93 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.94 out of 5 stars

3.3

Analyst's Opinion

Consensus Rating
Fresenius SE & Co. KGaA has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $31.40, Fresenius SE & Co. KGaA has a forecasted upside of 386.1% from its current price of $6.46.
Amount of Analyst Coverage
Fresenius SE & Co. KGaA has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.00% of the outstanding shares of Fresenius SE & Co. KGaA have been sold short.
Short Interest Ratio / Days to Cover
Fresenius SE & Co. KGaA has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Fresenius SE & Co. KGaA has recently increased by 210.42%, indicating that investor sentiment is decreasing significantly.

2.5

Dividend Strength

Dividend Yield
Fresenius SE & Co. KGaA pays a meaningful dividend of 2.57%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Fresenius SE & Co. KGaA does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Fresenius SE & Co. KGaA is 23.88%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Fresenius SE & Co. KGaA will have a dividend payout ratio of 17.20% next year. This indicates that Fresenius SE & Co. KGaA will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for FSNUY.

0.6

News and Social Media Coverage

News Sentiment
Fresenius SE & Co. KGaA has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Fresenius SE & Co. KGaA this week, compared to 1 article on an average week.
MarketBeat Follows
Only 1 people have added Fresenius SE & Co. KGaA to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

N/A

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Fresenius SE & Co. KGaA insiders have not sold or bought any company stock.

3.8

Earnings and Valuation

Earnings Growth
Earnings for Fresenius SE & Co. KGaA are expected to grow by 19.23% in the coming year, from $0.78 to $0.93 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Fresenius SE & Co. KGaA is 9.64, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 125.45.
Price to Earnings Ratio vs. Sector
The P/E ratio of Fresenius SE & Co. KGaA is 9.64, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 152.83.
Price to Book Value per Share Ratio
Fresenius SE & Co. KGaA has a P/B Ratio of 0.42. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Stock

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.

Receive FSNUY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FSNUY Stock News Headlines

March 18, 2023 | reuters.com

FREG.DE - | Stock Price & Latest News | Reuters

February 22, 2023 | msn.com

Shares in Fresenius down, FMC up after outlook and reshuffle

March 27, 2023 | Oxford Club (Ad)

My No. 1 dividend stock for a LIFETIME of income.

Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.

February 22, 2023 | seekingalpha.com

Fresenius stock rises as Q4 revenue grows, plans restructuring; sees 'headwinds' in FY23

February 22, 2023 | msn.com

Fresenius Medical Care Q4 Profit Slips Despite Higher Revenue, Simplifies Structure

February 22, 2023 | bloomberg.com

Fresenius Slides as Earnings Disappoint, Cloud CEO’s Revamp

February 22, 2023 | msn.com

Profit slips, but revenue rises at German health-care firm Fresenius

February 21, 2023 | msn.com

Earnings Preview For Fresenius Medical Care

March 27, 2023 | Oxford Club (Ad)

My No. 1 dividend stock for a LIFETIME of income.

Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.

February 21, 2023 | finance.yahoo.com

UPDATE 2-Fresenius unveils plan to simplify structure, potential profit fall

February 10, 2023 | msn.com

Fresenius considering deconsolidating dialysis subsidiary - Bloomberg

February 9, 2023 | reuters.com

Fresenius in talks about deconsolidation of FMC - WirtschaftsWoche

February 9, 2023 | msn.com

Fresenius Reviews Potential Sale of Stake in Dialysis Unit

January 20, 2023 | msn.com

Healthcare workers union petitions FDA to recall Fresenius dialysis machines

January 2, 2023 | finance.yahoo.com

Fresenius SE KGaA (ETR:FRE) shareholders have endured a 57% loss from investing in the stock five years ago

December 22, 2022 | marketwatch.com

With 3.3% CAGR, Hemodialysis & Peritoneal Dialysis Market to Witness A Pronounce Growth During 2023-2028 | 104 Pages Report

December 16, 2022 | finance.yahoo.com

Painful week for individual investors invested in Fresenius SE & Co. KGaA (ETR:FRE) after 3.3% drop, institutions also suffered losses

December 6, 2022 | msn.com

FMC gets new CEO after parent Fresenius flags business review

December 6, 2022 | msn.com

UPDATE 4-FMC boss leaves after two months as Fresenius pushes for changes

December 5, 2022 | bloomberg.com

Fresenius Dialysis Unit CEO to Leave Over Strategic Differences

December 2, 2022 | finance.yahoo.com

Why Is Nevro (NVRO) Up 14.9% Since Last Earnings Report?

November 29, 2022 | finance.yahoo.com

Is Now An Opportune Moment To Examine Fresenius SE & Co. KGaA (ETR:FRE)?

November 21, 2022 | theglobeandmail.com

$FME : Fresenius Medical Care Enters Monthly Buying Area

November 21, 2022 | uk.finance.yahoo.com

COMMERZBANK AG (London Branch) - Pre Stabilisation - Fresenius SE EUR 3.5yr & 7yr

November 21, 2022 | markets.businessinsider.com

EQS-AFR: Fresenius SE & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

November 9, 2022 | finance.yahoo.com

Fresenius SE KGaA Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags

November 8, 2022 | markets.businessinsider.com

Fresenius Medical Care North America Named Among 100 Healthiest Workplaces

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive FSNUY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FSNUY Company Calendar

Last Earnings: 2/21/2023
Today: 3/27/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:FSNUY
CUSIP: N/A
CIK: N/A
Web: www.fresenius.com
Phone: (496) 172-6080
Fax: N/A
Employees: 316,078
Year Founded: 1912

Price Target and Rating

Average Stock Price Forecast: $31.40
High Stock Price Forecast: $46.10
Low Stock Price Forecast: $24.00
Forecasted Upside/Downside: +398.4%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.67
Research Coverage: 9 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.67
Trailing P/E Ratio: 9.40
Forward P/E Ratio: 8.08
P/E Growth: N/A
Net Income: $1.45 billion
Net Margins: 3.50%
Pretax Margin: 8.74%
Return on Equity: 5.19%
Return on Assets: 2.18%

Debt

Debt-to-Equity Ratio: 0.58
Current Ratio: 1.32
Quick Ratio: 0.99

Sales & Book Value

Annual Sales: $43.04 billion
Price / Sales: 0.33
Cash Flow: $2.40 per share
Price / Cash Flow: 2.62
Book Value: $15.51 per share
Price / Book: 0.41

Miscellaneous

Outstanding Shares: 2,234,010,000
Free Float: N/A
Market Cap: $14.07 billion
Optionable: Not Optionable
Beta: 1.10

Social Links

Key Executives

Pierluigi Antonelli
Chief Executive Officer

Sara Hennicken
Chief Financial Officer

Rice Powell
Chief Executive Officer-Fresenius Medical Care

Francesco de Meo
Chief Executive Officer-Fresenius Helios

Ernst Wastler
Chief Executive Officer-Fresenius Vamed

Key Competitors

View All Competitors

FSNUY Stock - Frequently Asked Questions

Should I buy or sell Fresenius SE & Co. KGaA stock right now?: 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co. KGaA in the last year. There are currently 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" FSNUY shares.
View FSNUY analyst ratings or view top-rated stocks.
What is Fresenius SE & Co. KGaA's stock price forecast for 2023?: 9 equities research analysts have issued twelve-month price objectives for Fresenius SE & Co. KGaA's shares. Their FSNUY share price forecasts range from $24.00 to $46.10. On average, they anticipate the company's stock price to reach $31.40 in the next twelve months. This suggests a possible upside of 398.4% from the stock's current price.
View analysts price targets for FSNUY or view top-rated stocks among Wall Street analysts.
How have FSNUY shares performed in 2023?: Fresenius SE & Co. KGaA's stock was trading at $6.99 at the beginning of the year. Since then, FSNUY stock has decreased by 9.9% and is now trading at $6.30.
View the best growth stocks for 2023 here.
Are investors shorting Fresenius SE & Co. KGaA?: Fresenius SE & Co. KGaA saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 14,900 shares, an increase of 210.4% from the February 28th total of 4,800 shares. Based on an average trading volume of 102,200 shares, the days-to-cover ratio is presently 0.1 days.
View Fresenius SE & Co. KGaA's Short Interest.
How were Fresenius SE & Co. KGaA's earnings last quarter?: Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) announced its earnings results on Tuesday, February, 21st. The company reported $0.20 earnings per share for the quarter. The firm earned $10.87 billion during the quarter. Fresenius SE & Co. KGaA had a net margin of 3.50% and a trailing twelve-month return on equity of 5.19%.
Is Fresenius SE & Co. KGaA a good dividend stock?: Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) pays an annual dividend of $0.16 per share and currently has a dividend yield of 2.57%. The dividend payout ratio is 23.88%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FSNUY will have a dividend payout ratio of 17.20% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FSNUY.

What is Fresenius SE & Co. KGaA's stock symbol?: Fresenius SE & Co. KGaA trades on the OTCMKTS under the ticker symbol "FSNUY."
How do I buy shares of Fresenius SE & Co. KGaA?: Shares of FSNUY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Fresenius SE & Co. KGaA's stock price today?: One share of FSNUY stock can currently be purchased for approximately $6.30.
How much money does Fresenius SE & Co. KGaA make?: Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) has a market capitalization of $14.07 billion and generates $43.04 billion in revenue each year. The company earns $1.45 billion in net income (profit) each year or $0.67 on an earnings per share basis.
How many employees does Fresenius SE & Co. KGaA have?: The company employs 316,078 workers across the globe.
How can I contact Fresenius SE & Co. KGaA?: Fresenius SE & Co. KGaA's mailing address is Else-Kroner-Strasse 1, Bad Homburg 2M, 61352. The official website for the company is www.fresenius.com. The company can be reached via phone at (496) 172-6080 or via email at ir-fre@fresenius.com.

This page (OTCMKTS:FSNUY) was last updated on 3/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Fresenius SE & Co. KGaA - FSNUY Stock Forecast, Price & News

Fresenius SE & Co. KGaA MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Stock

FSNUY Stock News Headlines

FSNUY Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

FSNUY Stock - Frequently Asked Questions

Overall MarketRank^™